Pyrexia, commonly known as fever, remains a frequently encountered symptom in clinical practice. This article aims to provide a comprehensive guide to its management, focusing on the latest evidence-based approaches.
Pyrexia is a physiological response to a variety of conditions, most commonly infection. It is defined as a temporary elevation in the body's thermoregulatory set-point, typically characterized by a body temperature above 38°C (100.4°F). Understanding its underlying cause is crucial to formulating an effective management plan.
The diagnostic approach to pyrexia involves a thorough history and physical examination, with particular attention to potential sources of infection, travel history, and exposure to toxins or drugs. Laboratory investigations, including complete blood count, blood cultures, and specific serological tests, may be necessary depending on the clinical context. Imaging studies may also be warranted in certain cases.
Management of pyrexia primarily involves treating the underlying cause. Antipyretic medications such as acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) can be used to alleviate discomfort. However, their use should be judicious as fever is a natural defense mechanism of the body. In cases of hyperpyrexia (temperature >41.5°C or 106.7°F), immediate intervention to reduce body temperature is essential to prevent potential complications such as seizures and organ damage.
The prognosis of pyrexia is generally good with appropriate treatment. However, in cases of persistent or recurrent fever, a detailed evaluation for potential underlying conditions, including malignancies and autoimmune diseases, is warranted. Long-term management involves regular follow-up and monitoring, along with patient education on the significance of fever and when to seek medical help.
Pyrexia is a common symptom that requires a systematic approach for effective management. By understanding its causes and implementing evidence-based treatment strategies, clinicians can ensure optimal patient outcomes.
1.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
2.
Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?
3.
Chemo causes lasting physical decline in breast cancer survivors
4.
MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA
5.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
1.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
2.
Rehabilitation Following Bone Marrow Functional Suppression: Clinical Strategies and Advances
3.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
4.
Strategic Breakthroughs in Oncology in Clinical Decision-Making
5.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Early warning sings of camcer that need medical attention
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation